Sun Pharma and US-based Pharmazz to introduce cerebral ischemic stroke drug in India https://ift.tt/uLVhwWI

Under the terms of the agreement, Sun Pharma has been granted the rights to market Sovateltide in India using the brand name Tyvalzi™ (Sovateltide). In return, Pharmazz will receive upfront payments, milestone payments, and royalties as stipulated in the agreement.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/REaNOvd
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.